Jefferson J Doyle

Dr. Jefferson J Doyle

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2012 in FEBS Letters
Verified
Journal Article
Closed access
JDJefferson J Doyle
Jefferson J Doyle
EGElizabeth E. Gerber
Elizabeth E. Gerber
HDHarry C. Dietz
Harry C. Dietz

27 October 2015 in eLife
Verified
Journal Article
Open access
JDJefferson J Doyle
Jefferson J Doyle
ADAlexander J Doyle
Alexander J Doyle
NWNicole K Wilson
Nicole K Wilson
JHJennifer P Habashi
Jennifer P Habashi
DBDjahida Bedja
Djahida Bedja
MCMIBAVA Leducq Consortium
MIBAVA Leducq Consortium
Calcium channel blockers (CCBs) are prescribed to patients with Marfan syndrome for prophylaxis against aortic aneurysm progression, despite limited evidence for their efficacy and safety in the disorder. Unexpectedly, Marfan mice treated with CCBs show accelerated aneurysm expansion, rupture, and premature lethality. This effect is both extracellular signal-regulated kinase (ERK1/2) dependent and angiotensin-II type 1 receptor (AT1R) dependent. We have identified protein kinase C beta (PKCβ) as a critical mediator of this pathway and demonstrate that the PKCβ inhibitor enzastaurin, and the clinically available anti-hypertensive agent hydralazine, both normalize aortic growth in Marfan mice, in association with reduced PKCβ and ERK1/2 activation. Furthermore, patients with Marfan syndrome and other forms of inherited thoracic aortic aneurysm taking CCBs display increased risk of aortic dissection and need for aortic surgery, compared to patients on other antihypertensive agents.

15 April 2026 in Genetics in Medicine
Verified
Journal Article
Open access
GMGretchen MacCarrick
Gretchen MacCarrick
RARana O. Afifi
Rana O. Afifi
RARebecca Allen
Rebecca Allen
KAKonstantinia Almpani
Konstantinia Almpani
JBJames H. Black
James H. Black
HDHarry C. Dietz
Harry C. Dietz
Loeys-Dietz syndrome (LDS) represents a clinically and genetically heterogeneous group of connective tissue disorders that share features similar to Marfan syndrome, first identified in 2005. Characterized by significant manifestations, such as aortic aneurysms, arterial tortuosity, craniofacial and skeletal anomalies, LDS results from pathogenic variants in key genes of the transforming growth factor-beta signaling pathway. Given its variable expressivity, a multidisciplinary approach to management is critical. The article provides an updated overview of effective management practices since the first LDS primer in 2014. It aims to enhance clinical awareness, inform health care providers, and improve patient outcomes through individualized care strategies for those living with LDS.

21 January 2025 in JCI Insight
Verified
Journal Article
Open access
PDF file
CBCaitlin J. Bowen
Caitlin J. Bowen
RSRebecca Sorber
Rebecca Sorber
JGJuan Francisco Calderón Giadrosic
Juan Francisco Calderón Giadrosic
JDJefferson J Doyle
Jefferson J Doyle
GRGraham Rykiel
Graham Rykiel
HDHarry C. Dietz
Harry C. Dietz
Aortic dissection or rupture is a major cause of mortality in vascular Ehlers-Danlos syndrome (vEDS), a connective tissue disorder caused by heterozygous mutations in the collagen type III alpha 1 chain ( COL3A1 ) gene. C57BL6/J (BL6) mice carrying the Col3a1 G938D/+ mutation recapitulate the vEDS vascular phenotype and die suddenly of aortic rupture/dissection. However, 129S6/SvEvTac (referred to here as 129) mice expressing the same Col3a1 G938D/+ mutation show near-complete lifelong protection from vascular rupture. To identify genetic modifiers of vascular risk in vEDS, we performed genome-wide genotyping of intercrossed BL6/129 vEDS mice stratified by survival and identified a significant protective locus encompassing a variant in Map2k6 , encoding mitogen-activated protein kinase kinase 6 (M2K6), a p38-activating kinase. Genetic ablation of Map2k6 rendered previously protected 129 vEDS mice susceptible to aortic rupture, in association with reduced protein phosphatase 1 activity and increased PKC and ERK phosphorylation. Accelerated vascular rupture in vEDS mice treated with a pharmacological inhibitor of p38 was rescued by concomitant ERK antagonism, supporting an opposing role for ERK and p38 in the modification of aortic rupture risk in vEDS. These results suggest that pharmacologic strategies aimed at mimicking the effect of this natural protective pathway may attenuate aortic rupture risk in vEDS.

18 August 2025 in British Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
MRMaria Ludovica Ruggeri
Maria Ludovica Ruggeri
JDJefferson J Doyle
Jefferson J Doyle

30 January 2022 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
OLOded Lagstein
Oded Lagstein
RMRachel R. Milante
Rachel R. Milante
KMKapil Mishra
Kapil Mishra
JDJefferson J Doyle
Jefferson J Doyle
To report a case of a young adult with dense bilateral accessory iris membranes (AIMs). AIMs can influence vision by multiple mechanisms. We discuss clinical examination and imaging considerations that can help parse optical and refractive complications to better guide intervention discussions. We also describe our surgical approach and perioperative management to help minimize trauma to the eye and maximize favorable surgical outcomes in these cases. This case highlights the excellent symptomatic, visual acuity and stereopsis gains that can be achieved following surgical intervention for this clinical entity, even in older patients.